Long-term update of the 24954 EORTC phase III trial on larynx preservation

B. Henriques De Figueiredo, C. Fortpied, J. Menis, J. L. Lefebvre, L. Barzan, D. de Raucourt, L. Geoffrois, L. Giurgea, P. Hupperets, C. R. Leemans, L. Licitra, F. Rolland, M. Tesselaar, J. B. Vermorken, V. Grégoire

Research output: Contribution to journalArticle

Abstract

The long-term results of the EORTC 24954 trial comparing sequential versus alternating chemotherapy and radiotherapy (RT) for patients with locally advanced laryngeal and hypopharyngeal cancer are reported. From 1996 to 2004, 450 patients were randomly assigned (1–1) to a sequential arm (SA = induction cisplatin-5fluorouracil followed by a 70Gy-RT for the responders or a total laryngectomy and post-operative RT for the non-responders) and an alternating arm (AA = cisplatin-5fluorouracil alternated with three 2-week courses of 20 Gy-RT for a total dose of 60 Gy). Median follow-up was 10.2 years. Ten-year survival with functional larynx (primary end-point) and overall survival were similar in both arms (18.7% and 33.6% in SA versus 18.3% and 31.6% in AA). Late toxicity was also similar; however, a trend for higher larynx preservation and better laryngeal function was observed in AA.

Original languageEnglish
Pages (from-to)109-112
Number of pages4
JournalEuropean Journal of Cancer
Volume65
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Larynx
Radiotherapy
Cisplatin
Hypopharyngeal Neoplasms
Laryngectomy
Laryngeal Neoplasms
Survival
Drug Therapy

Keywords

  • Larynx preservation
  • Late toxicity
  • Radiochemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Henriques De Figueiredo, B., Fortpied, C., Menis, J., Lefebvre, J. L., Barzan, L., de Raucourt, D., ... Grégoire, V. (2016). Long-term update of the 24954 EORTC phase III trial on larynx preservation. European Journal of Cancer, 65, 109-112. https://doi.org/10.1016/j.ejca.2016.06.024

Long-term update of the 24954 EORTC phase III trial on larynx preservation. / Henriques De Figueiredo, B.; Fortpied, C.; Menis, J.; Lefebvre, J. L.; Barzan, L.; de Raucourt, D.; Geoffrois, L.; Giurgea, L.; Hupperets, P.; Leemans, C. R.; Licitra, L.; Rolland, F.; Tesselaar, M.; Vermorken, J. B.; Grégoire, V.

In: European Journal of Cancer, Vol. 65, 01.09.2016, p. 109-112.

Research output: Contribution to journalArticle

Henriques De Figueiredo, B, Fortpied, C, Menis, J, Lefebvre, JL, Barzan, L, de Raucourt, D, Geoffrois, L, Giurgea, L, Hupperets, P, Leemans, CR, Licitra, L, Rolland, F, Tesselaar, M, Vermorken, JB & Grégoire, V 2016, 'Long-term update of the 24954 EORTC phase III trial on larynx preservation', European Journal of Cancer, vol. 65, pp. 109-112. https://doi.org/10.1016/j.ejca.2016.06.024
Henriques De Figueiredo B, Fortpied C, Menis J, Lefebvre JL, Barzan L, de Raucourt D et al. Long-term update of the 24954 EORTC phase III trial on larynx preservation. European Journal of Cancer. 2016 Sep 1;65:109-112. https://doi.org/10.1016/j.ejca.2016.06.024
Henriques De Figueiredo, B. ; Fortpied, C. ; Menis, J. ; Lefebvre, J. L. ; Barzan, L. ; de Raucourt, D. ; Geoffrois, L. ; Giurgea, L. ; Hupperets, P. ; Leemans, C. R. ; Licitra, L. ; Rolland, F. ; Tesselaar, M. ; Vermorken, J. B. ; Grégoire, V. / Long-term update of the 24954 EORTC phase III trial on larynx preservation. In: European Journal of Cancer. 2016 ; Vol. 65. pp. 109-112.
@article{5651d96aa6b1496e9dd9b37d9fb8445d,
title = "Long-term update of the 24954 EORTC phase III trial on larynx preservation",
abstract = "The long-term results of the EORTC 24954 trial comparing sequential versus alternating chemotherapy and radiotherapy (RT) for patients with locally advanced laryngeal and hypopharyngeal cancer are reported. From 1996 to 2004, 450 patients were randomly assigned (1–1) to a sequential arm (SA = induction cisplatin-5fluorouracil followed by a 70Gy-RT for the responders or a total laryngectomy and post-operative RT for the non-responders) and an alternating arm (AA = cisplatin-5fluorouracil alternated with three 2-week courses of 20 Gy-RT for a total dose of 60 Gy). Median follow-up was 10.2 years. Ten-year survival with functional larynx (primary end-point) and overall survival were similar in both arms (18.7{\%} and 33.6{\%} in SA versus 18.3{\%} and 31.6{\%} in AA). Late toxicity was also similar; however, a trend for higher larynx preservation and better laryngeal function was observed in AA.",
keywords = "Larynx preservation, Late toxicity, Radiochemotherapy",
author = "{Henriques De Figueiredo}, B. and C. Fortpied and J. Menis and Lefebvre, {J. L.} and L. Barzan and {de Raucourt}, D. and L. Geoffrois and L. Giurgea and P. Hupperets and Leemans, {C. R.} and L. Licitra and F. Rolland and M. Tesselaar and Vermorken, {J. B.} and V. Gr{\'e}goire",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.ejca.2016.06.024",
language = "English",
volume = "65",
pages = "109--112",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Long-term update of the 24954 EORTC phase III trial on larynx preservation

AU - Henriques De Figueiredo, B.

AU - Fortpied, C.

AU - Menis, J.

AU - Lefebvre, J. L.

AU - Barzan, L.

AU - de Raucourt, D.

AU - Geoffrois, L.

AU - Giurgea, L.

AU - Hupperets, P.

AU - Leemans, C. R.

AU - Licitra, L.

AU - Rolland, F.

AU - Tesselaar, M.

AU - Vermorken, J. B.

AU - Grégoire, V.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The long-term results of the EORTC 24954 trial comparing sequential versus alternating chemotherapy and radiotherapy (RT) for patients with locally advanced laryngeal and hypopharyngeal cancer are reported. From 1996 to 2004, 450 patients were randomly assigned (1–1) to a sequential arm (SA = induction cisplatin-5fluorouracil followed by a 70Gy-RT for the responders or a total laryngectomy and post-operative RT for the non-responders) and an alternating arm (AA = cisplatin-5fluorouracil alternated with three 2-week courses of 20 Gy-RT for a total dose of 60 Gy). Median follow-up was 10.2 years. Ten-year survival with functional larynx (primary end-point) and overall survival were similar in both arms (18.7% and 33.6% in SA versus 18.3% and 31.6% in AA). Late toxicity was also similar; however, a trend for higher larynx preservation and better laryngeal function was observed in AA.

AB - The long-term results of the EORTC 24954 trial comparing sequential versus alternating chemotherapy and radiotherapy (RT) for patients with locally advanced laryngeal and hypopharyngeal cancer are reported. From 1996 to 2004, 450 patients were randomly assigned (1–1) to a sequential arm (SA = induction cisplatin-5fluorouracil followed by a 70Gy-RT for the responders or a total laryngectomy and post-operative RT for the non-responders) and an alternating arm (AA = cisplatin-5fluorouracil alternated with three 2-week courses of 20 Gy-RT for a total dose of 60 Gy). Median follow-up was 10.2 years. Ten-year survival with functional larynx (primary end-point) and overall survival were similar in both arms (18.7% and 33.6% in SA versus 18.3% and 31.6% in AA). Late toxicity was also similar; however, a trend for higher larynx preservation and better laryngeal function was observed in AA.

KW - Larynx preservation

KW - Late toxicity

KW - Radiochemotherapy

UR - http://www.scopus.com/inward/record.url?scp=84979934307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979934307&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2016.06.024

DO - 10.1016/j.ejca.2016.06.024

M3 - Article

AN - SCOPUS:84979934307

VL - 65

SP - 109

EP - 112

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -